» Articles » PMID: 19910618

Transforaminal 5% Phenol Neurolysis for the Treatment of Intractable Cancer Pain

Overview
Journal Anesth Analg
Specialty Anesthesiology
Date 2009 Nov 14
PMID 19910618
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

This is the first case report of using a transforaminal approach for phenol administration. A 76-yr-old patient with a history of leiomyosarcoma and multiple metastatic lesions had unremitting pain in the right thoracic and lumbar regions and had prohibitive opioid-induced side effects. The patient underwent phenol neurolysis using a transforaminal approach in 2 stages at 3 levels (L3-4, L1-2, and T12-L1). The patient had complete resolution of pain, without any complications, and opioid treatment was nearly discontinued. Transforaminal phenol neurolysis is a reasonable treatment option for patients suffering from intractable pain for whom conventional therapies have proven ineffective.

Citing Articles

Indian Society for Study of Pain, Cancer Pain Special Interest Group Guidelines on Interventional Management for Cancer Pain.

Ahmed A, Thota R, Chatterjee A, Jain P, Ramanjulu R, Bhatnagar S Indian J Palliat Care. 2020; 26(2):203-209.

PMID: 32874034 PMC: 7444568. DOI: 10.4103/0973-1075.285696.


Pain Intervention for Cancer and Non-cancer Pain: A Retrospective Analysis of Tertiary Care Hospital Experience.

Ahmad U, Abbas S, Hamadani S, Abbas S, Usman S, Hafeez Z Cureus. 2020; 12(4):e7719.

PMID: 32431997 PMC: 7234092. DOI: 10.7759/cureus.7719.


New Cancer Pain Treatment Options.

Candido K, Kusper T, Knezevic N Curr Pain Headache Rep. 2017; 21(2):12.

PMID: 28265859 DOI: 10.1007/s11916-017-0613-0.


The role of chemical neurolysis in cancer pain.

Koyyalagunta D, Burton A Curr Pain Headache Rep. 2010; 14(4):261-7.

PMID: 20524161 DOI: 10.1007/s11916-010-0123-9.